Inventergy Global is an intellectual property (IP) investment and licensing company that identifies, acquires and licenses the patented technologies of technology companies. INVT offers a professional corporate licensing model for IP value creation that provides short term returns and long-term … Continue reading →

Innovus Pharmaceuticals is an emerging leader in OTC consumer products for men’s and women’s health and vitality. The company generates revenues from its lead products Zestra (R) for female arousal, and EjectDelay(TM) for premature ejaculation, and has a total of … Continue reading →

DARA BioSciences is an oncology supportive care pharmaceutical company dedicated to providing health care professionals a portfolio of medicines to help cancer patients stick to their therapy and manage side effects arising from their cancer treatment. DARA holds exclusive U.S. … Continue reading →

Direct Insite provides a powerful platform for unified working capital management that facilitates more than $160 billion worth of transactions annually between more than 375,000 companies worldwide. Its clients include IBM, Hewlett-Packard, Siemens, BE Aerospace, Saint Gobain and Carlson. The … Continue reading →

Nuvel Holdings designs, develops and sells a family of appliances, software and services that secure, accelerate and optimize the delivery of business applications, web content, and other information to distributed users over a wide area network (WAN) or across an … Continue reading →

RiceBran Technologies is a global leader in the production and marketing of value-added products derived from rice bran. The company has proprietary and patented intellectual property that allows it to convert rice bran, one of the world’s most underutilized food … Continue reading →

Nephros, a commercial stage medical device company, develops and sells high-performance liquid purification ultra-filters and an online mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of patients with end stage renal disease. Its ultra-filters are primarily … Continue reading →

Interleukin Genetics develops and markets proprietary genetic tests for chronic diseases and health-related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its … Continue reading →

NovaBay Pharmaceuticals is a biopharmaceutical company focused on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global topical anti-infective market with its two distinct product categories: the NEUTROX™ Family of Products, including AVENOVA™ … Continue reading →

NeuroVive Pharmaceutical AB is involved in the research and development of mitochondrial-protecting pharmaceuticals in Sweden and Hong Kong. The company’s product portfolio includes its drug candidate CicloMulsion, which is in phase 3 clinical study for cell protection against reperfusion injury … Continue reading →